Charlie Gourley
MB ChB, PhD
Professor of Medical Oncology
👥Biography 个人简介
Charlie Gourley leads translational and clinical research on high-grade serous carcinoma (HGSOC) biology and fallopian tube origin, including studies supporting salpingectomy as a cancer prevention intervention. He leads the UKBOCS (UK and Ireland BRCA1/2 Cohort Study) and has contributed to characterizing BRCA1 reversion mutations as a mechanism of PARP inhibitor resistance. His Edinburgh group has published extensively on genomic predictors of PARP inhibitor sensitivity and resistance in the ovarian/fallopian tube/peritoneal carcinoma spectrum.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Charlie Gourley 的研究动态
Follow Charlie Gourley's research updates
留下邮箱，当我们发布与 Charlie Gourley（University of Edinburgh / Cancer Research UK Edinburgh Centre）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment